If you spend any meaningful time on Instagram or TikTok in 2026, you have probably been served an ad for SculptHer — usually a soft-lit kitchen scene, a woman in her forties laughing about bladder leaks, and a promise that ten minutes a day with a discreet wand can do what years of Kegels could not. The pitch is unusually direct, the claims are unusually bold, and the comments under the ads are an unusually mixed bag. So we did what readers keep asking us to do: we spent two weeks taking the brand apart.
The product in question is the SculptHer PelviRestore, a small, internal EMS (electrical muscle stimulation) device that the company markets as a home alternative to the in-clinic pelvic-floor therapy chairs that can run $200 to $400 per session. The marketing copy describes EMS pulses that activate deep pelvic muscles most women cannot consciously engage. The brand voice is warm, woman-to-woman, and occasionally evangelical. The pricing — $149.95 for the device, with a recurring lubricant subscription on the upsell — sits at the higher end of mass-market wellness but well below clinic alternatives.
None of that, on its own, tells you whether SculptHer works. So here is what we found.
What SculptHer Actually Is
SculptHer is the consumer brand behind a women's wellness line targeting postpartum recovery, perimenopausal pelvic-floor weakness, and bladder-control issues. Its catalog includes three core products: the PelviRestore EMS device, an Intimacy Wand using red-light therapy, and the Silk Glide intimate lubricant. The PelviRestore is the flagship, and the brand reports having served more than 50,000 customers to date — a figure consistent with the volume of paid social impressions the brand is currently buying.
The underlying technology — EMS for pelvic-floor activation — is real and well-established. Devices in this category have been studied in clinical settings, and the mechanism (low-grade electrical stimulation prompting involuntary muscle contractions) is the same one used in physiotherapy clinics. That does not mean every consumer device is equivalent to a clinical one. It means the category is not pseudoscience, which is more than can be said for many products in adjacent corners of the wellness market.
The HSA / FSA Question
One of the more meaningful legitimacy markers for any health-adjacent device is whether it qualifies for HSA or FSA reimbursement. SculptHer is HSA/FSA eligible through Truemed, the third-party provider of the IRS-required Letter of Medical Necessity. In practice, this means a customer pays out of pocket at checkout, receives an LMN through Truemed if they qualify, and then submits the receipt to their plan administrator for reimbursement.
Two things are worth understanding about this. First, this is not the same as a product being on a blanket pre-approved FSA list — no consumer device in this category is. Eligibility hinges on the LMN and on the customer's individual plan. Second, the fact that Truemed has approved SculptHer as a participating merchant is a real diligence check; Truemed reviews the product category and the medical-necessity rationale before granting eligibility. Brands like Eight Sleep and Oura use the same pathway, so SculptHer is in defensible company.
The practical implication: for a customer with an active HSA or FSA, the effective cost of the device can drop meaningfully. For a customer without one, the eligibility is mostly a credibility signal that the brand's medical framing is taken seriously by an independent third party.
What 786 Customers Actually Say
SculptHer's customer review hub, accessible at sculptherus.com/pages/reviews, currently displays 786 verified reviews collected through the Judge.me review platform. The average rating is 4.7 out of 5 stars. The breakdown is striking: 78% are five-star, 18% four-star, 2% three-star, 1% two-star, and 1% one-star. By any reasonable benchmark for direct-to-consumer wellness devices, that is a strong distribution.
The positive reviews cluster around three themes. The first is noticeable engagement quickly: dozens of reviewers describe feeling muscle activation within the first one or two sessions, sometimes phrased in a tone of mild surprise. The second is cost relief versus clinic alternatives: multiple reviewers mention having spent significant amounts on in-clinic pelvic-floor therapy or EMS sessions before discovering the device. The third is discretion and ease of use: the at-home format, simple setup, and short ten-minute session length come up repeatedly as factors that turned an intimidating treatment into a sustainable habit.
The negative reviews — small in number but worth reading — cluster around two themes. A handful of reviewers describe device hardware issues (charging failures, faulty units), with mixed reports of how quickly customer service resolved them. A separate small group describes results that were marginal or slow to appear after six to eight weeks of consistent use. Notably absent from the dataset are complaints about safety or about the device being unsafe to use; the criticism is about reliability and individual response variability, not about the device's underlying premise.
The Cost Argument
Perhaps the strongest part of SculptHer's pitch is straightforwardly economic. The brand frames the cost of long-term pelvic-floor management like this:
These figures come from SculptHer's own marketing and should be read as ballpark rather than audited. That said, they are not implausible. In-clinic EMS pelvic-floor sessions in major U.S. metros routinely run $200 to $400 each, and a typical course of treatment is six to twelve sessions. Even discounting the brand's framing, the math leans in the device's favor for any user who would otherwise pursue clinic-based care.
The Marketing Worth Flagging
Two patterns are worth knowing about before you buy. First, the site uses persistent urgency mechanics — "Mother's Day Sale ends Sunday" banners, "89% sold" stock counters, and a rotating "50% off" headline that, in our testing, never actually expired. None of this is unique to SculptHer; it is the standard playbook of the entire DTC wellness category. But readers deserve to recognize a perpetual sale for what it is.
Second, the brand uses language like "clinically backed" and "designed with women's health specialists." These are softer claims than "FDA-cleared" or "clinically tested," and the distinction is meaningful. The underlying EMS category has clinical literature behind it; the specific PelviRestore device is sold as a wellness product, not as a regulated medical device. For most users in most use cases this is a fine distinction. For postpartum, post-surgical, or medically complex users, it is a reason to involve a clinician before buying.